IDXX Maintains Overweight Rating with JP Morgan -- Price Target Lowered to $750

gurufocus.com · 2026-10-16

IDEXX Laboratories (IDXX) Analyst Rating Update On %B %d, %Y, JP Morgan maintained an Overweight rating for IDEXX Laboratories (IDXX). However, the price tar

TickrTrends take: JP Morgan's maintenance of an overweight rating on IDXX while lowering its price target to $750 suggests analyst confidence in the company's fundamentals despite near-term headwinds or valuation adjustments. This action occurs within a context where TickrTrends currently identifies IDXX as undervalued, indicating potential misalignment between the market's current pricing and the company's intrinsic worth as measured by valuation metrics. Investors focused on valuation should monitor whether the revised price target influences the gap between current market price and IDXX's assessed fair value, particularly given the company's position in the Healthcare sector.

Read the full story at gurufocus.com →